Resources

Selected
  • Systematic reviews (SYSVAC)
  • Pregnant women
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

270 results found

2024 ∙ Shah, M. P. Morgan, C. J. Beeson, J. G. Peach, E. Davis, J. McPake, B. Wallace, A. S.

Integrated Approaches for the Delivery of Maternal and Child Health Services with Childhood Immunization Programs in Low- and Middle-Income Countries: Systematic Review Update 2011-2020

  • Pregnant women
  • Newborn
  • Children
  • Low and Middle Income Countries
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Briga, M. Goult, E. Brett, T. S. Rohani, P. Domenech de Celles, M.

Maternal pertussis immunization and the blunting of routine vaccine effectiveness: a meta-analysis and modeling study

  • Pregnant women
  • Pertussis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Oliveira, J. A. Silva, E. G. Karasu, A. F. G. Silva, A. M. N. Philip, C. E.

Neonatal and Maternal Outcomes of mRNA Compared With Non-mRNA Vaccinations in Pregnant Patients With COVID-19: A Systematic Review and Meta-Analysis

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Hamouda, N. I. Amin, A. M. Hasan, M. T. Baghagho, E.

Persistence of COVID-19 Human Milk Antibodies After Maternal COVID-19 Vaccination: Systematic Review and Meta-Regression Analysis

  • Parents/caregivers
  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Properzi, S. Sepioni, M. S. Carestia, R. Cervelli, G. de Waure, C.

Promoting Vaccinations in Pregnancy: Results of a Systematic Literature Review of Italian Initiatives

  • Europe
  • Italy
  • Pregnant women
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Mapindra, M. P. Mahindra, M. P. McNamara, P. Semple, M. G. Clark, H. Madsen, J.

Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy

  • Pregnant women
  • Newborn
  • RSV (Respiratory syncytial virus)
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Phijffer, Ewem de Bruin, O. Ahmadizar, F. Bont, L. J. Van der Maas, N. A. T. Sturkenboom, Mcjm Wildenbeest, J. G. Bloemenkamp, K. W. M.

Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes

  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2024 ∙ Ciapponi, A. Berrueta, M. Argento, F. J. Ballivian, J. Bardach, A. Brizuela, M. E. Castellana, N. Comandé, D. Gottlieb, S. Kampmann, B. Mazzoni, A. Parker, E. P. K. Sambade, J. M. Stegelmann, K. Xiong, X. Stergachis, A. Buekens, P.

Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis

  • Pregnant women
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Gerede, A. Daskalakis, G. Mikos, T. Chatzakis, C. Vavoulidis, E. Eleftheriades, M. Domali, E. Nikolettos, K. Oikonomou, E. Antsaklis, P. Theodora, M. Psarris, A. Margioula-Siarkou, C. Petousis, S. Stavros, S. Potiris, A. Athanasiadis, A. Dinas, K. Tsikouras, P. Nikolettos, N. Sotiriadis, A.

Safety of COVID-19 Vaccination in Pregnancy: A Systematic Review

  • Pregnant women
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Malik, M. Bauer-Maison, N. Guarna, G. D. Souza RD

Social media misinformation about pregnancy and COVID-19 vaccines: A systematic review

  • Pregnant women
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...